Upon cancer progression, different immune escape mechanisms take place, including the onset of tolerance to cancer-associated antigens (especially when similar to natural antigens) and overexpression of CTLA-4, PD-1, or PD-L1, to inhibit the cytotoxic effect of CTLs on tumor cells. The gene discussed is CD274; the disease is cancer.